Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz


1. Clarithromycin Citrate (1:1)
2. 16k08r7ng0
3. Erythromycin, 6-o-methyl-, 2-hydroxy-1,2,3-propanetricarboxylate (salt) (1:1)
4. 848130-51-8
5. Unii-16k08r7ng0
6. Schembl6275870
7. Clarithromycin Citrate [who-dd]
8. Q27251822
| Molecular Weight | 940.1 g/mol |
|---|---|
| Molecular Formula | C44H77NO20 |
| Hydrogen Bond Donor Count | 8 |
| Hydrogen Bond Acceptor Count | 21 |
| Rotatable Bond Count | 13 |
| Exact Mass | 939.50389385 g/mol |
| Monoisotopic Mass | 939.50389385 g/mol |
| Topological Polar Surface Area | 315 Ų |
| Heavy Atom Count | 65 |
| Formal Charge | 0 |
| Complexity | 1420 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 18 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
40
PharmaCompass offers a list of UNII-16K08R7NG0 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right UNII-16K08R7NG0 manufacturer or UNII-16K08R7NG0 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred UNII-16K08R7NG0 manufacturer or UNII-16K08R7NG0 supplier.
PharmaCompass also assists you with knowing the UNII-16K08R7NG0 API Price utilized in the formulation of products. UNII-16K08R7NG0 API Price is not always fixed or binding as the UNII-16K08R7NG0 Price is obtained through a variety of data sources. The UNII-16K08R7NG0 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Clarithromycin citrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Clarithromycin citrate, including repackagers and relabelers. The FDA regulates Clarithromycin citrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Clarithromycin citrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Clarithromycin citrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Clarithromycin citrate supplier is an individual or a company that provides Clarithromycin citrate active pharmaceutical ingredient (API) or Clarithromycin citrate finished formulations upon request. The Clarithromycin citrate suppliers may include Clarithromycin citrate API manufacturers, exporters, distributors and traders.
click here to find a list of Clarithromycin citrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Clarithromycin citrate written confirmation (Clarithromycin citrate WC) is an official document issued by a regulatory agency to a Clarithromycin citrate manufacturer, verifying that the manufacturing facility of a Clarithromycin citrate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Clarithromycin citrate APIs or Clarithromycin citrate finished pharmaceutical products to another nation, regulatory agencies frequently require a Clarithromycin citrate WC (written confirmation) as part of the regulatory process.
click here to find a list of Clarithromycin citrate suppliers with Written Confirmation (WC) on PharmaCompass.
Clarithromycin citrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Clarithromycin citrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Clarithromycin citrate GMP manufacturer or Clarithromycin citrate GMP API supplier for your needs.
A Clarithromycin citrate CoA (Certificate of Analysis) is a formal document that attests to Clarithromycin citrate's compliance with Clarithromycin citrate specifications and serves as a tool for batch-level quality control.
Clarithromycin citrate CoA mostly includes findings from lab analyses of a specific batch. For each Clarithromycin citrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Clarithromycin citrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Clarithromycin citrate EP), Clarithromycin citrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Clarithromycin citrate USP).